Clinical Trial

Implementation of a HABIT-ILE Intervention at Home for Children With Bilateral Cerebral Palsy

Study acronym: HABITILEhome
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 6, 2023 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Intensive interventions based on the principles of motor skill learning, like Hand-Arm Bimanual Therapy Including Lower Extremities (HABIT-ILE), have demonstrated excellent effectiveness in improving motor function and daily life independence of children with cerebral palsy (CP). Patients living far from big cities do not have easy access to such interventions, usually applied in the form of camps. This randomized controlled trial will include 48 children with bilateral CP and aims to test a home version of HABIT-ILE with the use of a specifically designed virtual device and a remote supervision. For this purpose, two types of two weeks intensive treatment programs will be compared: Hand and Arm Bimanual Intensive Therapy Including Lower Extremities at home ("HABIT-ILE at home") and "classic HABIT-ILE". Moreover, this study also aims to assess whether the patient's abilities are better with a follow-up at home after two weeks of HABIT-ILE therapy than without follow-up post therapy. Four groups will be compared: HABIT-ILE at home therapy with a follow-up at home, HABIT-ILE at home therapy without follow-up, classic HABIT-ILE therapy with a follow-up at home and classic HABIT-ILE therapy without follow-up. Children will be assessed at 3 time points: before therapy, after therapy and 3 months after the start of therapy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-02-13.
Status change: Not Yet Recruiting → Recruiting 2023-03-03
Trial Details
NCT Number NCT05740605
Lead Sponsor Université Catholique de Louvain
Conditions Cerebral Palsy
Enrollment 48 participants
Start Date 2023-02-22
Primary Completion 2025-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-03-06